EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Circulating Tumor DNA: A Breakthrough in Oncological Analyses

Zihui Gao, Ali Sinehsepehr, Seyed Hadi Hashemi iD, Rangaswamy Roopashree, Golnoush Mohammadifar iD, Vishal Thakur iD, Gholamreza Bahoush, Subhashree Ray iD, Mehul Manu, Shahab Masoumi iD

Journal of Biochemical and Molecular Toxicology · 2026-06 · 40 (6)

DOI: 10.1002/jbt.70921 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Biochemical and Molecular Toxicology, online erschienen am 12.06.2026. Verfasst von Zihui Gao und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Basic Medical Sciences, China Three Gorges University, Yichang, Hubei, China. Hauptthemen laut MEDLINE: Circulating Tumor DNA, Neoplasms, Biomarkers, Tumor. Die Arbeit nennt 211 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Circulating tumor DNA (ctDNA), a fragment of cell‐free DNA derived from malignant cells, has emerged as a promising biomarker in oncology. These DNA fragments carry essential genomic and epigenetic alterations, including point mutations, loss of heterozygosity, copy number variations, and promoter hypermethylation of tumor suppressor genes. ctDNA analysis enables non‐invasive detection of these molecular changes, providing valuable insights into tumor biology. Moreover, abnormal methylation patterns in ctDNA—either hypo‐ or hypermethylation—often manifest at early stages of tumorigenesis and act as predictive indicators. The concentration and molecular profile of ctDNA correlate with tumor type, stage, and location, making it an effective tool for early cancer diagnosis, prognosis assessment, and treatment monitoring. This review summarizes the current advancements in ctDNA analysis, discusses its clinical applications across various cancer types, and highlights existing technical and biological challenges in ctDNA‐based diagnostics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Circulating Tumor DNANeoplasmsBiomarkers, TumorHumansDNA Methylation

Stichwörter der Autor:innen

Point mutationcancerctDNAlaboratory biomarkermethylation

Substanzen

Circulating Tumor DNABiomarkers, Tumor

Autor:innen und Institutionen

  • College of Basic Medical Sciences, China Three Gorges University, Yichang, Hubei, China.
  • School of Medicine, Golestan University of Medical Sciences, Gorgan, Iran.
  • School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Department of Chemistry and Biochemistry, School of Sciences, JAIN (Deemed to be University), Bangalore, Karnataka, India.
  • Department of Pharmaceutical Sciences, Medical University of Gdansk, Gdansk, Poland.
  • Centre for Research Impact & Outcome, Chitkara University Institute of Engineering and Technology, Chitkara University, Rajpura, Punjab, India.

ORCID-Profile: Seyed Hadi Hashemi, Golnoush Mohammadifar, Vishal Thakur, Subhashree Ray, Shahab Masoumi

Zitieren

APA

Gao, Z., Sinehsepehr, A., Hashemi, S. H., Roopashree, R., Mohammadifar, G., Thakur, V., Bahoush, G., Ray, S., Manu, M., & Masoumi, S. (2026). Circulating Tumor DNA: A Breakthrough in Oncological Analyses. Journal of Biochemical and Molecular Toxicology, 40(6). https://doi.org/10.1002/jbt.70921

Vancouver

Gao Z, Sinehsepehr A, Hashemi SH, Roopashree R, Mohammadifar G, Thakur V, et al. Circulating Tumor DNA: A Breakthrough in Oncological Analyses. Journal of Biochemical and Molecular Toxicology. 2026;40(6). doi:10.1002/jbt.70921

BibTeX
@article{Gao2026,
  author = {Gao, Zihui and Sinehsepehr, Ali and Hashemi, Seyed Hadi and Roopashree, Rangaswamy and Mohammadifar, Golnoush and Thakur, Vishal and Bahoush, Gholamreza and Ray, Subhashree and Manu, Mehul and Masoumi, Shahab},
  title = {Circulating Tumor DNA: A Breakthrough in Oncological Analyses},
  journal = {Journal of Biochemical and Molecular Toxicology},
  year = {2026},
  volume = {40},
  number = {6},
  doi = {10.1002/jbt.70921}
}
Kostenlos starten →